ReviewDrug design, development and therapy2019

Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy.

Thomas G Cotter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.